
    
      -  Collection of epidemiological data on non-high-risk APL patients aged ≤ 70 years: age
           and sex distribution, medical history, prognostic factors (time to treatment start,
           severity of coagulopathy at presentation, Performance status…).

        -  Documentation of clinical and biologic effectiveness of the two first-line treatment
           approaches available for non-high-risk APL patients.

        -  Documentation of Minimal Residual Disease (MRD).

        -  Correlation of clinical outcomes with the chosen therapy.

        -  Validation of published prognostic factors and identification of new prognostic factors
    
  